Cargando…

COVID-19 associated mucormycosis (CAM): A tale of two pathogens

Detalles Bibliográficos
Autores principales:	Pustake, Manas, Giri, Purushottam, Ganiyani, Mohammad Arfat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884292/ https://www.ncbi.nlm.nih.gov/pubmed/35280646 http://dx.doi.org/10.4103/jfmpc.jfmpc_1514_21

Ejemplares similares

The hepatitis virus infection and renal replacement therapies: What is the relation?
por: Pustake, Manas, et al.
Publicado: (2022)

Increasing antimicrobial resistance in Salmonella isolates across the Indian subcontinent: Is our response to this threat satisfactory?
por: Pustake, Manas, et al.
Publicado: (2023)

Controlling the spread of HIV with targeted interventions: A new way of combating the HIV epidemic in India
por: Pustake, Manas, et al.
Publicado: (2023)

Omicron and other variants of SARS-CoV-2 roles of vaccines and herd immunity in protecting from the emerging strains
por: Pustake, Manas, et al.
Publicado: (2022)

MDR and XDR typhoid fever-a threat for the current decade?
por: Pustake, Manas, et al.
Publicado: (2021)

Drawing Parallels between SARS, MERS, and COVID-19: A Comparative Overview of Epidemiology, Pathogenesis, and Pathological Features
por: Pustake, Manas, et al.
Publicado: (2023)

Post Chikungunya Fever and Post COVID-19 Bilateral Pedal Edema: A Case Report
por: Pustake, Manas, et al.
Publicado: (2022)

Extensively Drug-Resistant Typhoid Fever: A Call to Action
por: Pustake, Manas, et al.
Publicado: (2022)

Drug Utilization Study of Antidiabetic Drugs in Patients Attending Geriatric Outpatient Department at a Tertiary Care Hospital
por: Hannan, Abdul, et al.
Publicado: (2021)

Pathogenesis of COVID-19-associated mucormycosis (CAM) in India: probing the triggering factors
por: Arakeri, Gururaj, et al.
Publicado: (2022)

COVID-associated mucormycosis (CAM): is the Delta variant a cause?
por: Arakeri, Gururaj, et al.
Publicado: (2022)

COVID-19 associated Mucormycosis (CAM): Should Brazil be on alert?
por: Farias, Luís Arthur Brasil Gadelha, et al.
Publicado: (2021)

SARS, MERS and CoVID-19: An overview and comparison of clinical, laboratory and radiological features
por: Pustake, Manas, et al.
Publicado: (2022)

Comparison of public health measures taken during Spanish flu and COVID-19 pandemics: A Narrative Review
por: Tambolkar, Sampada, et al.
Publicado: (2022)

COVID-19 and orbital mucormycosis
por: Sarkar, Sandip, et al.
Publicado: (2021)

COVID-19 associated mucormycosis - a recent challenge
por: dos Santos, Vitorino Modesto, et al.
Publicado: (2023)

Mucormycosis in COVID-19: The Indian scenario
por: Ghosh, Ritwik, et al.
Publicado: (2022)

Concurrent plexiform ameloblastoma and COVID-19-associated mucormycosis of the maxilla
por: Ingle, Yashwant, et al.
Publicado: (2022)

COVID-19-Associated Mucormycosis in Diabetic Patients: The Tip of an Iceberg
por: Parsaei, Amirhossein, et al.
Publicado: (2022)

Additional insights on COVID-associated mucormycosis
por: Panta, Prashanth
Publicado: (2022)

COVID-19-Associated Mucormycosis (CAM): An Updated Evidence Mapping
por: Hussain, Salman, et al.
Publicado: (2021)

A Tale of Two Systems
por: Spaeth, George L.
Publicado: (2011)

Prevention of mucormycosis in COVID-19 – the need of the hour
por: Ish, Pranav, et al.
Publicado: (2021)

Triple challenge of diabetes, COVID-19, and mucormycosis
por: Rastogi, Ashu, et al.
Publicado: (2021)

Mucormycosis Following COVID-19 Infections: an Insight
por: Das, Srijit, et al.
Publicado: (2021)

Mucormycosis: A killer in the shadow of COVID-19
por: Suvvari, Tarun Kumar, et al.
Publicado: (2021)

Mitigating the Emerging Threat of Mucormycosis in COVID-19
por: Pothiawala, Sohil
Publicado: (2021)

COVID-19 and Rhino-Cerebral Mucormycosis: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Comment to: “Association of COVID-19 with Rhino-Cerebral Mucormycosis: An Observational Study”
por: Vaidyanathan, Aiswarya, et al.
Publicado: (2022)

Be vigilant in treating a patient with diabetes and COVID-19-associated mucormycosis
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2023)

Have the COVID-19 pandemic and lockdown affected children’s mental health in the long term? A repeated cross-sectional study
por: Pustake, Manas, et al.
Publicado: (2022)

Comments on: Rise of the phoenix: Mucormycosis in COVID-19 times
por: Singh, Awadhesh K, et al.
Publicado: (2021)

Mucormycosis—A serious threat in the COVID-19 pandemic?
por: Szarpak, Lukasz, et al.
Publicado: (2021)

Should statins be considered for the management of mucormycosis in COVID-19?
por: Chatterjee, Subhankar, et al.
Publicado: (2021)

COVID-19 Associated Mucormycosis and Anbarnesa: Concerning about Important Source of Spores
por: Pourazizi, Mohsen, et al.
Publicado: (2022)

COVID-19 Associated Mucormycosis: Ramping up our services during crisis
por: Xess, Immaculata, et al.
Publicado: (2022)

Palliative oral care for COVID-19 associated oral mucormycosis in diabetic patients
por: Rathee, Manu, et al.
Publicado: (2022)

COVID-19 associated mucormycosis (CAM) in India: a formidable challenge
por: Rao, Vishal U.S., et al.
Publicado: (2021)

The surge in Covid related mucormycosis
por: Chandra, Somesh, et al.
Publicado: (2021)

Use of Azithromycin in COVID-19: A Cautionary Tale
por: Kow, Chia Siang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ggukk8vuotqr1td1ptkpam121b